Advertisement
Canada markets open in 8 hours 58 minutes
  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CAD/USD

    0.7319
    -0.0001 (-0.02%)
     
  • CRUDE OIL

    83.45
    +0.09 (+0.11%)
     
  • Bitcoin CAD

    91,220.11
    +456.08 (+0.50%)
     
  • CMC Crypto 200

    1,436.25
    +21.49 (+1.52%)
     
  • GOLD FUTURES

    2,340.30
    -1.80 (-0.08%)
     
  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • NASDAQ futures

    17,728.00
    +121.25 (+0.69%)
     
  • VOLATILITY

    15.69
    -1.25 (-7.38%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • NIKKEI 225

    38,381.23
    +829.07 (+2.21%)
     
  • CAD/EUR

    0.6832
    -0.0004 (-0.06%)
     

Can Teva’s Debt Repayment Plan Deleverage Its Balance Sheet?

Can Teva’s Debt Repayment Plan Deleverage Its Balance Sheet?

Can Teva Pharmaceutical's Restructuring Plan Help It Recuperate? Teva Pharmaceutical Industries (TEVA) has a debt of $34 billion on its balance sheet. The company is focused on reducing its net debt obligations to optimum levels over the coming years.